Prenetics sells its genomic medicine business and plans to explore Bitcoin treasury management strategies.

On June 18, according to the official announcement, consumer health sciences company Prenetics (NASDAQ: PRE) announced that it has reached a definitive agreement to transfer its ownership of its genomic medicine business ACT Genomics Holdings to Delta Electronics (TWSE: 2308), with a total transaction value of up to $71.78 million, and Prenetics is expected to receive about $46 million in cash. Upon completion of the transaction, the company will increase its cash reserves to $86 million and short-term assets of $117 million, while maintaining zero debt. CEO Danny Yeung said that the abundant cash reserves will allow the company to explore innovative financial strategies such as digital assets and bitcoin treasury management.

View Original
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • 4
  • Share
Comment
0/400
AirdropSweaterFanvip
· 23h ago
This financial situation is something.
Reply0
ChainMaskedRidervip
· 06-18 13:30
Selling Bitcoin? You really dare to think that.
Reply0
just_here_for_vibesvip
· 06-18 13:26
So you're really just chewing on Bitcoin, huh?
Reply0
QuorumVotervip
· 06-18 13:25
Sell assets to buy coins? This operation is awesome.
Reply0
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)